Back to Report Store Home

Pharmaceutical Lifecycle Management Strategies in 2017

  • Published: Apr-2017
  • Report Code: GBI078CBR
  • Report Format: pdf

Description

GBI Research’s latest report Pharmaceutical Lifecycle Management Strategies in 2017 provides a comprehensive assessment of product lifecycle (LCM) management strategies that are being implemented by pharmaceutical companies around the world. The pharmaceutical industry remains highly competitive and lucrative, and companies are investing significant time and resources into implementing strategies aimed at preserving the revenue streams of their products by extending patent life, delaying competition or slowing the pace of revenue loss following the end of market exclusivity.

The study, delivered in the form of an 82-slide PowerPoint presentation investigates a wide range of commercial, developmental, legal and regulatory strategies. This report format allows you to easily assemble high-quality presentations and research material to meet a variety of corporate requirements. Our research deep dives into the rationale for implementing LCM strategies, as well as the challenges, risks and commercial opportunities they represent. Moreover, detailed case studies showcasing recent real-world examples of LCM strategies will enable understanding of the key factors that determined their success. Information leveraged from our robust industry-leading database also highlights strategies being implemented for products currently in development.

The pharmaceutical industry will continue to face a wide range of challenges in the coming years, including patent cliffs, declining productivity, intensifying levels of competition from generic and biosimilar manufacturers, low reimbursement levels and stricter regulatory policies. Careful LCM planning will continue to be a crucial element of the industry’s ability to answer these problems.

GBI Research conducted extensive research to provide a comprehensive understanding of the LCM strategies being implemented by players in the pharmaceutical industry. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising commercial areas in the market and exploit key business opportunities.

Scope

  • What is driving the need for effective LCM strategies in the pharmaceutical industry?

  • What are the most common LCM strategies being implemented?

  • What are the business opportunities and commercial rewards arising from the implementation of LCM strategies?

  • What are the key factors that impact the choice of LCM strategy?

  • What strategies have Big Pharma companies implemented in recent years to preserve revenues and market share?

Reasons To Buy

  • This report will allow you to:

  • Gain insights into the rationale for implementing LCM strategies, alongside their key challenges, risks and potential benefits.

  • Understand the key challenges that the pharmaceutical industry has been facing in recent years

  • Assess real-world examples of successful strategies implemented in the past, and the key factors that determined their success.

  • Obtain information on strategies for products currently in development.

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
Special Offer
Expires on 18 August 2017
15% OFF
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$2546 $2995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$5092 $5990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$7638 $8985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5817
Or click here to contact us
Secure Payments
Cards